Live Breaking News & Updates on Trial Assessing

Stay updated with breaking news from Trial assessing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report . ....

South Australia , United States , New Zealand , Joel Latham , Redomiciling Incannex , Peter Widdows , April Incannex , Drug Administration , Early Phase Clinical Research , Incannex Healthcare , Clinical Research , Iv Clinical Research , Quest Pharmaceutical Services , Clarion Clinics Group Pty Ltd , Human Research Ethics Committee , Clarion Clinics Group , European Union Medicines Agency , Corporate Governance Council Principles , Disclosure Committee , Apirx Pharmaceuticals , Incannex Healthcare Inc , Obstructive Sleep Apnoea , Obstructive Sleep , Investigational New Drug , Trial Investigating , Managing Director ,

Date: July 13, 2023 Public Announcement (NASDAQ

Date: July 13, 2023

Public Announcement

Incannex Receives HREC Approval for Phase. ....

New Zealand , United States , New South Wales , Joel Latham , Mark Bleackley , Sullivan Asia Pacific , Bellberry Human Research Ethics Committee , Incannex Healthcare , Edison Group , Australian Stock Exchange , Incannex Healthcare Limited , Incannex Healthcare Limited Nasdaq , Trial Assessing , Emeritus Research , Placebo Controlled Clinical Trial , Avance Clinical , Healthcare Limited , Rialto South Tower , Active Pharmaceutical Ingredients , Patient Reported Outcomes , Chief Scientific Officer Dr Mark Bleackley , Melbourne Victoria , Sydney New South , All Emeritus Research , North American , Leadership Award ,

Use of Standing Orders for PP-CSF to Improve Adherence to Prescribing Guidelines

Reliance on automated standing orders for prescribing primary prophylaxis colony-stimulating factor did not significantly impact its use. ....

Trial Assessing ,

G1 Therapeutics Provides Second Quarter 2022 Financial Results and Operational Highlights

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

Normane Ned Sharpless , Jack Bailey , National Cancer Institute , National Institutes Of Health , International Society For Pharmacoeconomics , Outcomes Research , Drug Administration On , China National Medical Products Administration , Therapeutics Inc , Manufacturing Supply Of Merck Co , Research Triangle Park , Net Revenue , Second Quarter , Total Revenue , Patient Enrollment , Pivotal Phase , Metastatic Colorectal Cancer , Action Trial , Neoadjuvant Triple Negative Breast Cancer , Target Enrollment , Bladder Cancer , Host Webcast , Conference Call , Chief Executive Officer , Cash Equivalents , Trial Assessing ,

ADDF-Funded Investigators to Present Findings at Next Week's Conference on Alzheimer's & Parkinson's Diseases (AD/PD™ 2021)

Share this article
Share this article
NEW YORK, March 8, 2021 /PRNewswire/ The Alzheimer s Drug Discovery Foundation (ADDF) announced today that four of its funded researchers will be making presentations at the 15
th International Conference on Alzheimer s and Parkinson s Diseases (AD/PD™ 2021), which will be held virtually from Barcelona, Spain March 9-14, 2021.
The ADDF seeks out and maintains a diverse portfolio of novel drug and biomarker targets that reflect the many biological pathways implicated in Alzheimer s disease, said Dr. Howard Fillit, Founding Executive Director and Chief Science Officer of the ADDF. We are excited to hear the latest updates from these investigators on some of the novel approaches we have supported since the early phases of research. ....

Comunidad Autonoma De Cataluna , Vastra Gotalands Lan , Frank Longo , Howard Fillit , Ronalds Lauder , Chrisj Edgar , Marwan Sabbagh , Henrik Zetterberg , Las Vegas , Gothenburg University , International Conference On Alzheimer Parkinson Diseases , Alzheimer Drug Discovery Foundation , International Conference On Alzheimer , Stanford University , Cleveland Clinic Lou Ruvo Center , Brain Health , Drug Discovery Foundation , International Conference , Founding Executive Director , Chief Science Officer , Clinical Trials , Cogstate Brief Battery , At Home Cognitive Assessment , Trial Assessing , Mild Cognitive Impairment , Preclinical Assessment ,